首页> 外文期刊>Nephron >Comparative nephritogenicity of two monoclonal antibodies that recognize different epitopes of rat Thy-1.1 molecule.
【24h】

Comparative nephritogenicity of two monoclonal antibodies that recognize different epitopes of rat Thy-1.1 molecule.

机译:识别大鼠Thy-1.1分子不同表位的两种单克隆抗体的比较产肾性。

获取原文
获取原文并翻译 | 示例
           

摘要

The pathophysiological role of the Thy-1.1 molecule expressed on rat mesangial cells with regard to mesangial cell dysfunction and injury remains unknown. The mechanism of Thy-1.1-associated injury has now been investigated with two monoclonal antibodies, 1-22-3 and OX7, that recognize different epitopes of Thy-1.1. Mesangiolysis and mesangial cell proliferation were more marked in rats injected with 1-22-3 than in those treated with OX7. Immunostaining for rat complement component C3 and also C9 was similar in the kidneys of rats 1 h after injection of either antibody. Alpha smooth muscle actin was first detected 3 days after injection of 1-22-3 and peaked on day 5; type I collagen staining showed a mesangial pattern on days 5 and 10. The staining for alpha smooth muscle actin and type I collagen was less intense in OX7-treated rats than in the 1-22-3-injected rats. The amounts of mRNAs encoding collagen types I and III peaked 5 days after injection of 1-22-3 and 10 days after injection of OX7. Rats injected with 1-22-3 developed proteinuria that was already marked on day 1 and peaked at 150 mg/day on day 3, whereas OX7 induced a low grade of proteinuria with large interindividual variability on day 3. Immunostaining for rat C3 in the normal rat kidneys, incubated in vitro with 1-22-3 or OX7 followed by incubation with normal rat fresh serum as a complement source, as well as the levels of serum complement activity, CH50, 30 min after injection of 1-22-3 or OX7 were similar, suggesting that the difference in the nephritogenicity of these two antibodies is not attributable to a difference in their complement-fixing activities, but rather may result from the difference in epitope specificities. The epitope recognized by 1-22-3 thus appears to be important in the initiation and progression of antibody-induced nephritis.
机译:关于系膜细胞功能障碍和损伤,在大鼠系膜细胞上表达的Thy-1.1分子的病理生理作用仍然未知。现在已经用两种单克隆抗体1-22-3和OX7研究了Thy-1.1相关损伤的机制,它们识别Thy-1.1的不同表位。注射1-22-3的大鼠中的血管溶解和肾小球膜细胞增殖比用OX7处理的大鼠更明显。注射任何一种抗体1小时后,大鼠肾脏中的大鼠补体成分C3和C9的免疫染色均相似。注射1-22-3后3天首次检测到α平滑肌肌动蛋白,并在第5天达到峰值; I型胶原蛋白染色在第5天和第10天显示出肾小球系膜模式。用OX7处理的大鼠中α平滑肌肌动蛋白和I型胶原蛋白的染色强度不如注射1-22-3的大鼠。注射1-22-3后5天和注射OX7后10天,编码I和III型胶原的mRNA的量达到峰值。注射1-22-3的大鼠会在第1天出现明显的蛋白尿,并在第3天达到150 mg /天的峰值,而OX7在第3天诱导蛋白尿水平低,个体间存在较大差异。正常大鼠肾脏,在体外与1-22-3或OX7一起孵育,然后与正常大鼠新鲜血清作为补体来源一起孵育,并在注射1-22-3后30分钟内血清补体活性水平CH50或OX7相似,表明这两种抗体的肾生成能力的差异并非归因于补体固定活性的差异,而可能是由于表位特异性的差异所致。因此,1-22-3识别的表位在抗体诱导的肾炎的发生和发展中似乎很重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号